State warns blood banks over unethical profit through bulk transfers

State Blood Transfusion Council issues warning to blood banks against collecting excess blood and transferring it in bulk to other states for profit

Pune:  The State Blood Transfusion Council (SBTC) has issued a strict warning to blood banks against collecting excess blood and transferring it in bulk to other states for profit, officials said on Saturday.

The SBTC recently directed all blood centre heads across Maharashtra to adhere to guidelines, following complaints that some centres were deliberately collecting far more blood than needed. Allegations indicate that surplus components, especially packed red blood cells (PRBCs), were being transferred out of state or supplied to plasma fractionation companies for commercial gain, violating norms.

Dr Purushottam Puri, Assistant Director, SBTC, said, “Blood centres found violating SBTC guidelines, engaging in bulk transfers or profit-oriented practices will face strict action. Recommendations will be made to the Food and Drug Administration for cancellation of licences of such centres.”

The warning comes ahead of multiple blood donation camps planned for occasions such as Shiv Jayanti and Mahashivratri, organised by religious and social groups. Officials noted that while these camps are vital for ensuring an uninterrupted supply for patients, some centres have been collecting excessive blood and transferring it outside the state or selling it to plasma fractionators, leading to profiteering.

Dr Nisha Teli, Head of Pune District Blood Bank, said, “Following the orders, we have instructed all private blood centres to collect only the required quantity. Such practices defeat the core purpose of voluntary donation, which is to meet local patient needs. Centres with excess stock should share it with nearby government blood banks.”

Maharashtra has 373 blood banks registered with SBTC, including 57 public and private centres in Pune district.

Related Posts

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus board approved a buyback of up to Rs 1100 crore at Rs 1,150 per share, along with a 100 percent dividend for FY26. Zydus Lifesciences reported a rise in…

Chemists strike on May 20: Reasons behind today’s all-India strike

While major pharmacy chains and government medical outlets will remain operational, the strike highlights significant tensions within the industry that could impact access to medications nationwide. The All India Organisation…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Zydus Lifesciences Q4FY26 net profit rises 9%

Zydus Lifesciences Q4FY26 net profit rises 9%

Chemists strike on May 20: Reasons behind today’s all-India strike

Chemists strike on May 20: Reasons behind today’s all-India strike

AbbVie loses patent plea for Hep C drug

AbbVie loses patent plea for Hep C drug

GSK’s Calpol a well-known trademark: High Court

GSK’s Calpol a well-known trademark: High Court

3 arrested for allegedly posing as doctors using forged MBBS degrees

3 arrested for allegedly posing as doctors using forged MBBS degrees

Commissioner FDA reviews enforcement measures

Commissioner FDA reviews enforcement measures